Structure-based drug design: progress, results and challenges.

Protein structure-based drug design is rapidly gaining momentum. The new opportunities, developments and results in this field are almost unbelievable compared with the situation less than a decade ago.

[1]  N. Cohen,et al.  The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. , 1993, Journal of medicinal chemistry.

[2]  James W. Pflugrath.  Developments in X-ray detectors , 1992 .

[3]  Owen Johnson,et al.  The development of versions 3 and 4 of the Cambridge Structural Database System , 1991, J. Chem. Inf. Comput. Sci..

[4]  L. Caliguiri,et al.  Effect of arildone on modifications of poliovirus in vitro. , 1980, Virology.

[5]  R. Hoess,et al.  Phage display of peptides and protein domains , 1993 .

[6]  A. Tulinsky,et al.  Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors. , 1994, Biochemistry.

[7]  M. Murcko,et al.  GroupBuild: a fragment-based method for de novo drug design. , 1993, Journal of medicinal chemistry.

[8]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[9]  A Itai,et al.  Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. , 1993, Journal of medicinal chemistry.

[10]  S E Ealick,et al.  Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the methylene group. , 1993, Journal of medicinal chemistry.

[11]  D. Matthews,et al.  Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones. , 1993, Journal of medicinal chemistry.

[12]  R Weiss.  On the track of "killer" TB. , 1992, Science.

[13]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[14]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[15]  C. Betzel,et al.  Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution , 1992, Nature.

[16]  Mark A. Murcko,et al.  GenStar: A method for de novo drug design , 1993, J. Comput. Aided Mol. Des..

[17]  Paul Kellam,et al.  Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro , 1993, Nature.

[18]  Michael Famulok,et al.  In Vitro Selection of Specific Ligand‐binding Nucleic Acids , 1992 .

[19]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[20]  William Fisanick,et al.  Experimental system for similarity and 3D searching of CAS registry substances. 1. 3D substructure searching , 1993, J. Chem. Inf. Comput. Sci..

[21]  A. Tulinsky,et al.  The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. , 1994, The Journal of biological chemistry.

[22]  P. Loll,et al.  The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 , 1994, Nature.

[23]  C. Wilson,et al.  Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. , 1989, Science.

[24]  I. Campbell,et al.  NMR at very high fields. , 1994, Structure.

[25]  Dagmar Ringe,et al.  Analogous inhibitors of elastase do not always bind analogously , 1994, Nature Structural Biology.

[26]  N. W. Murrall,et al.  Conformational freedom in 3-D databases. 1. Techniques , 1990, J. Chem. Inf. Comput. Sci..

[27]  Valerie J. Gillet,et al.  SPROUT: A program for structure generation , 1993, J. Comput. Aided Mol. Des..

[28]  Richard A. Lewis,et al.  Automated site-directed drug design : the formation of molecular templates in primary structure generation , 1989, Proceedings of the Royal Society of London. B. Biological Sciences.

[29]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[30]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[31]  I. Kuntz,et al.  Automated docking with grid‐based energy evaluation , 1992 .

[32]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.

[33]  A. Leach,et al.  Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.

[34]  David A. Matthews,et al.  Structure of and kinetic channelling in bifunctional dihydrofolate reductase–thymidylate synthase , 1994, Nature Structural Biology.

[35]  Randy J. Read,et al.  A multiple‐start Monte Carlo docking method , 1992 .

[36]  E. Keith Davies,et al.  Conformational Freedom in 3-D Databases , 1993 .

[37]  C. Walsh,et al.  Vancomycin resistance: decoding the molecular logic. , 1993, Science.

[38]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[39]  David A. Pearlman,et al.  CONCEPTS: New dynamic algorithm for de novo drug suggestion , 1993, J. Comput. Chem..

[40]  Steven E. Ealick,et al.  Synchrotron beamlines for macromolecular crystallography , 1993 .

[41]  D. Goodsell,et al.  Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.

[42]  Gebhard F. X. Schertler,et al.  Overproduction of membrane proteins , 1992 .

[43]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[44]  M. Lawrence,et al.  CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure , 1992, Proteins.

[45]  A. Pardi,et al.  Isotope labelling for NMR studies of biomolecules , 1992 .

[46]  Patricia C. Weber,et al.  Crystal structure and ligand-binding studies of a screened peptide complexed with streptavidin. , 1992 .

[47]  Paul A. Bartlett,et al.  Caveat a program to facilitate the structure derived design of biologically active molecules , 1989 .

[48]  PatrickY.-S. Lam,et al.  Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.

[49]  Y. Martin,et al.  3D database searching in drug design. , 1992, Journal of medicinal chemistry.

[50]  S E Ealick,et al.  Structure-based design of inhibitors of purine nucleoside phosphorylase. , 1995, Acta crystallographica. Section D, Biological crystallography.

[51]  M Kahn,et al.  Peptide mimetics of the thrombin-bound structure of fibrinopeptide A. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Peter A. Kollman,et al.  Theory of macromolecule-ligand interactions , 1994 .

[53]  Yvonne C. Martin,et al.  ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures , 1989, J. Comput. Aided Mol. Des..

[54]  M. Noble,et al.  The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes , 1991, Proteins.

[55]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[56]  L. Kuyper,et al.  Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues. , 1982, Journal of medicinal chemistry.

[57]  Gareth Jones,et al.  Pharmacophoric pattern matching in files of three-dimensional chemical structures: Comparison of conformational-searching algorithms for flexible searching , 1994, J. Chem. Inf. Comput. Sci..

[58]  Keith D. Watenpaugh,et al.  Macromolecular crystallography at cryogenic temperatures: Current Opinion in Structural Biology 1991, 1: 1012–1015 , 1991 .

[59]  C L Verlinde,et al.  Structure of the complex between trypanosomal triosephosphate isomerase and N‐hydroxy‐4‐phosphono‐butanamide: Binding at the active site despite an “open” flexible loop conformation , 1992, Protein science : a publication of the Protein Society.

[60]  Edward D. T. Atkins.  Macromolecular Structures 1991 , 1993 .

[61]  F E Cohen,et al.  Structure-based inhibitor design by using protein models for the development of antiparasitic agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  N. Xuong,et al.  Dihydrofolate reductase from Lactobacillus casei. X-ray structure of the enzyme methotrexate.NADPH complex. , 1978, Journal of Biological Chemistry.

[63]  David J. Derosier.  Turn-of-the-century electron microscopy , 1993, Current Biology.

[64]  M S Chapman,et al.  A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. , 1994, Journal of molecular biology.

[65]  M. Karplus,et al.  Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.

[66]  Ronald N. Zuckermann,et al.  The chemical synthesis of peptidomimetic libraries: Current opinion in structural biology 1993, 3:580–584 , 1993 .

[67]  A. Petros,et al.  Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. , 1993, Biochemistry.

[68]  Wim G. J. Hol,et al.  PROTEIN CRYSTALLOGRAPHY AND COMPUTER-GRAPHICS TOWARD RATIONAL DRUG DESIGN , 1986 .

[69]  W. Howe,et al.  Computer design of bioactive molecules: A method for receptor‐based de novo ligand design , 1991, Proteins.

[70]  S. P. Fodor,et al.  Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. , 1994, Journal of medicinal chemistry.

[71]  Jan Hermans.  An editorial comment: The limits of simulations , 1993 .

[72]  Richard A. Lewis,et al.  Automated site-directed drug design: the concept of spacer skeletons for primary structure generation , 1989, Proceedings of the Royal Society of London. B. Biological Sciences.

[73]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[74]  Chris M. W. Ho,et al.  FOUNDATION: A program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases , 1993, J. Comput. Aided Mol. Des..

[75]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[76]  Barry A. Bunin,et al.  A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives , 1992 .